PRISMM

PRISMM

PLEASE READ: This study is designed for patients with metastatic (stage IV) breast cancer (any subtype). The study in particular is interested in splicesome mutations, in particular SF3B1. If you have this mutation, it should be written on your report. If you do not have metastatic breast cancer and the SF3B1 mutation, the tumor board will not formally review your records, however, you will receive an automated email with general information about select mutations if applicable.

  • Name Name *
  • Date of Birth Date of Birth * / /
    Pick a date.
  • Address Address *
  • Phone Number Phone Number * - -
  • Address of Primary Oncologist Address of Primary Oncologist *
  • Phone Number of Primary Oncologist Phone Number of Primary Oncologist * - -
  • Molecular Genetics Testing Lab *
    Molecular Genetics Testing Lab
  • Contact Agreement *
    Contact Agreement
  • Donate My Data
    Donate My Data